Amcor, a pioneer in responsible packaging solutions development and production, announced today that it has reached an agreement to buy Shanghai-based MDK. MDK, a market leader in medical device packaging and a key priority growth area for Amcor, has annual sales of about $50 million.
Amcor’s existing portfolio is enhanced by MDK’s coating capabilities, medical paper-based packaging options, and client base, further solidifying Amcor’s dominant position in the Chinese medical device packaging industry. With four manufacturing facilities now covering the China, India, Japan, and Southeast Asia regions, the purchase of MDK also reinforces Amcor’s position as the industry leader in the larger Asia Pacific medical packaging area.
“As Amcor continues to sharpen its focus on higher growth priority segments, the addition of MDK will enhance our already strong healthcare platform in the Asia Pacific region”, “MDK’s talented team brings strong capabilities and a complementary product and customer portfolio. We look forward to working together to unlock value creation opportunities for customers in this fast-growing, high-value segment, which we believe will help us continue to deliver strong returns for our shareholders.”
Ron Delia, CEO, Amcor
Following the introduction of a cutting-edge facility for specialised healthcare packaging in Singapore and the opening of Amcor’s new world-class Asia Pacific Innovation Center in Jiangyin, China, and the acquisition of MDK, respectively, last year.
The transaction is expected to close in the first quarter of 2023, subject to usual regulatory approvals.
